Literature DB >> 16407377

A molecular revolution in the study of intestinal microflora.

E Furrie1.   

Abstract

Bacterial colonisers of the colon comprise several hundred bacterial species that live in a complex ecosystem. Study of this complex ecosystem has been carried out, until recently, by traditional culture techniques with biochemical methods to identify organisms. The development of molecular techniques to investigate ecological microbial communities has provided the microbiologist with a vast array of new techniques to investigate human intestinal microflora. Metagenomics, the science of biological diversity, combines the use of molecular biology and genetics to identify and characterise genetic material from complex microbial environments. The combination of metagenomics and subsequent quantitation of each identified species using molecular techniques allows the relatively rapid analysis of whole bacterial populations in human health and disease.

Entities:  

Mesh:

Year:  2006        PMID: 16407377      PMCID: PMC1856515          DOI: 10.1136/gut.2005.081695

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis.

Authors:  Sandra Macfarlane; Elizabeth Furrie; John H Cummings; George T Macfarlane
Journal:  Clin Infect Dis       Date:  2004-05-25       Impact factor: 9.079

2.  Human colonic biota studied by ribosomal DNA sequence analysis.

Authors:  K H Wilson; R B Blitchington
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

3.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

4.  Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR.

Authors:  Xander W Huijsdens; Ronald K Linskens; Mariëtte Mak; Stephan G M Meuwissen; Christina M J E Vandenbroucke-Grauls; Paul H M Savelkoul
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.

Authors:  E Furrie; S Macfarlane; A Kennedy; J H Cummings; S V Walsh; D A O'neil; G T Macfarlane
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

6.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

Review 7.  Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.

Authors:  Michael Schultz; Jürgen Schölmerich; Heiko C Rath
Journal:  Dig Dis       Date:  2003       Impact factor: 2.404

8.  Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction.

Authors:  A Fite; G T Macfarlane; J H Cummings; M J Hopkins; S C Kong; E Furrie; S Macfarlane
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

9.  The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis.

Authors:  T Bamba; H Matsuda; M Endo; Y Fujiyama
Journal:  J Gastroenterol       Date:  1995-11       Impact factor: 7.527

Review 10.  Metagenomics for studying unculturable microorganisms: cutting the Gordian knot.

Authors:  Patrick D Schloss; Jo Handelsman
Journal:  Genome Biol       Date:  2005-08-01       Impact factor: 13.583

View more
  20 in total

1.  Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?

Authors:  Magnus Simrén
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

2.  A randomised trial of sheathed versus standard forceps for obtaining uncontaminated biopsy specimens of microbiota from the terminal ileum.

Authors:  Maneesh Dave; Laura A Johnson; Seth T Walk; Vincent B Young; Ryan W Stidham; Meghana N Chaudhary; Jessica Funnell; Peter D R Higgins
Journal:  Gut       Date:  2011-02-11       Impact factor: 23.059

3.  Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study.

Authors:  John Penders; Carel Thijs; Piet A van den Brandt; Ischa Kummeling; Bianca Snijders; Foekje Stelma; Hanne Adams; Ronald van Ree; Ellen E Stobberingh
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

4.  Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles.

Authors:  Johan Dicksved; Helen Flöistrup; Anna Bergström; Magnus Rosenquist; Göran Pershagen; Annika Scheynius; Stefan Roos; Johan S Alm; Lars Engstrand; Charlotte Braun-Fahrländer; Erika von Mutius; Janet K Jansson
Journal:  Appl Environ Microbiol       Date:  2007-02-09       Impact factor: 4.792

5.  Biochemical properties of two cinnamoyl esterases purified from a Lactobacillus johnsonii strain isolated from stool samples of diabetes-resistant rats.

Authors:  Kin Kwan Lai; Graciela L Lorca; Claudio F Gonzalez
Journal:  Appl Environ Microbiol       Date:  2009-06-05       Impact factor: 4.792

6.  The active human gut microbiota differs from the total microbiota.

Authors:  Francesc Peris-Bondia; Amparo Latorre; Alejandro Artacho; Andrés Moya; Giuseppe D'Auria
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

7.  Ecological characterization of the colonic microbiota of normal and diarrheic dogs.

Authors:  Julia A Bell; Jamie J Kopper; Judy A Turnbull; Nicholas I Barbu; Alice J Murphy; Linda S Mansfield
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-01-13

8.  Developmental and Reproductive Effects of SE5-OH: An Equol-Rich Soy-Based Ingredient.

Authors:  Ray A Matulka; Ikuo Matsuura; Tohru Uesugi; Tomomi Ueno; George Burdock
Journal:  J Toxicol       Date:  2008-12-15

9.  Exploring bacterial diversity in hospital environments by GS-FLX Titanium pyrosequencing.

Authors:  Margarita Poza; Carmen Gayoso; Manuel J Gómez; Soraya Rumbo-Feal; María Tomás; Jesús Aranda; Ana Fernández; Germán Bou
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

Review 10.  The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity.

Authors:  Outi Vaarala; Mark A Atkinson; Josef Neu
Journal:  Diabetes       Date:  2008-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.